Table 3. . Multimodal MRI biomarkers associated with 1p/19q co-deletion.
Study | n | Histology | MRI features | Ref. |
---|---|---|---|---|
Chawla S et al. | 40 | WHO grade II and III OD | rCBVmax and metabolite ratios | [13] |
Emblem K et al. | 52 | WHO grade II and III OD and OA | High rCBV | [32] |
Fellah S et al. | 50 | WHO grade II and III OD and OA | Higher rCBV and rCBF within grade II oligodendroglial subgroup | [28] |
Jenkinson MD et al. | 37 | WHO grade II and III OD and OA | Higher rCBV (>1.59) | [27] |
Jenkinson MD et al. | 17 | WHO grade II and III OD and OA | Lower maximum and histogram ADC Lower ATC | [38] |
Khayal IS et al. | 30 | WHO grade II AS, OD and OA | Lower median normalized ADC (<1.8) | [35] |
Walker C et al. | 59 | WHO grade II and III OD and OA | Increased 201Tl uptake | [39] |
ADC: Apparent diffusion coefficient; ATC: ADC transition coefficient; AS: Astrocytomas; OA: Oligoastrocytomas; OD: Oligodendroglioma; rCBF: Relative cerebral blood flow; rCBV: Relative cerebral blood volume.